These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14181919)

  • 21. [THE CARDIOVASCULAR MANIFESTATIONS OF THE GROENBLAD-STRANDBERG SYNDROME].
    FOUCAULT JP
    Arch Ophtalmol Rev Gen Ophtalmol; 1963 Sep; 23():561-74. PubMed ID: 14092065
    [No Abstract]   [Full Text] [Related]  

  • 22. [NECROTIC CHANGES IN THE EXTREMITIES IN ARTERIAL DISEASES].
    NOWICKI S
    Pol Przegl Chir; 1964 Feb; 36():139-43. PubMed ID: 14148333
    [No Abstract]   [Full Text] [Related]  

  • 23. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
    LINKE H
    Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726
    [No Abstract]   [Full Text] [Related]  

  • 24. [IMPORTANCE OF THE NERVOUS MECHANISMS IN THE PATHOGENESIS OF PERIPHERAL OBLITERATING ARTERIOPATHY (CLINICAL CONTRIBUTION)].
    PRATESI F; BARTOLI V
    Rass Neurol Veg; 1963 Dec; 17():301-19. PubMed ID: 14122982
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Further observations on therapy with intrathecal phenol solutions].
    PAPO I; VISCA A
    Minerva Med; 1963 Jun; 54():1713-4. PubMed ID: 13941318
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical treatment of peripheral vascular disease: are there new perspectives?
    Smit AJ
    Vasa Suppl; 1992; 34():20-4. PubMed ID: 1529413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CURRENT STATUS OF SYMPATHECTOMY.
    PALUMBO LT
    Clin Med (Northfield); 1963 Nov; 70():2035-42. PubMed ID: 15446085
    [No Abstract]   [Full Text] [Related]  

  • 30. [CLINICAL EFFECTIVENESS OF VERINA (NYLIDRIN HYDROCHLORIDE)].
    TAKAO H; KIMURA M; NORII T
    Chiryo; 1963; 45():2268-70. PubMed ID: 14103596
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of thrombocytic-vascular and coagulative hemostasis in the pathogenesis of the Raynaud's phenomenon].
    Slutsker GE; Promakhina EK
    Vestn Khir Im I I Grek; 1990 Apr; 144(4):40-3. PubMed ID: 2173227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug treatment of peripheral vascular disease.
    Eberhardt RT; Coffman JD
    Heart Dis; 2000; 2(1):62-74. PubMed ID: 11728242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiographic diagnosis of Raynaud's disease].
    Müller JH; Heyn G; Waigand J
    Z Gesamte Inn Med; 1974 Oct; 29(20):847-50. PubMed ID: 4464714
    [No Abstract]   [Full Text] [Related]  

  • 35. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 36. [LUNBAR SYMPATHECTOMY IN OBLITERATIVE ATHEROSCLEROSIS].
    MASLOVA MG
    Vestn Khir Im I I Grek; 1964 Apr; 92():70-2. PubMed ID: 14225761
    [No Abstract]   [Full Text] [Related]  

  • 37. [ADAPTATION AND THE USE OF VASODILATOR AGENTS IN CIRCULATORY DISEASES].
    MASHITA K; TANABE F; IWAMOTO M
    Chiryo; 1964; 46():386-95. PubMed ID: 14124010
    [No Abstract]   [Full Text] [Related]  

  • 38. [Value of a vasodilator derived from beta-phenylethylamine in vascular pathology].
    FERRAND M; ROUMAGNAC H; EHRHART C
    Alger Medicale; 1959 Oct; 63():961-6. PubMed ID: 13822363
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of vasodilator drugs in four patients with arteriosclerosis obliterans.
    TEXTER EC; REDISCH W; SHECKMAN E; FERGUSON S; STEELE JM
    Am J Med Sci; 1952 Oct; 224(4):408-12. PubMed ID: 12976385
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic use of prostacyclin in cardiovascular pathology].
    Martelli M; Nicolosi G
    Minerva Med; 1983 Nov; 74(44):2665-70. PubMed ID: 6419178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.